CGEM
Cullinan Oncology Inc

369
Mkt Cap
$424.74M
Volume
712,012.00
52W High
$17.50
52W Low
$5.68
PE Ratio
-1.95
CGEM Fundamentals
Price
$7.19
Prev Close
$7.35
Open
$7.24
50D MA
$7.05
Beta
1.09
Avg. Volume
1.45M
EPS (Annual)
-$3.11
P/B
0.94
Rev/Employee
$0.00
Loading...
Loading...
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
111

Frequently Asked Questions

What is Market Cap of Cullinan Therapeutics Inc?
What is the 52-week high for Cullinan Therapeutics Inc?
What is the 52-week low for Cullinan Therapeutics Inc?
What is Cullinan Therapeutics Inc stock price today?
What was Cullinan Therapeutics Inc stock price yesterday?
What is the PE ratio of Cullinan Therapeutics Inc?
What is the Price-to-Book ratio of Cullinan Therapeutics Inc?
What is the 50-day moving average of Cullinan Therapeutics Inc?
How many employess does Cullinan Therapeutics Inc has?

Latest CGEM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.